Calamos Advisors LLC raised its position in Agilent Technologies Inc (NYSE:A) by 4.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 497,735 shares of the medical research company’s stock after purchasing an additional 22,121 shares during the quarter. Calamos Advisors LLC owned approximately 0.16% of Agilent Technologies worth $38,141,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of A. Flagship Harbor Advisors LLC boosted its stake in shares of Agilent Technologies by 139.0% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock worth $26,000 after acquiring an additional 203 shares in the last quarter. Capital Investment Advisory Services LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $26,000. Liberty Wealth Management LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $29,000. WealthStone Inc. acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $31,000. Finally, Coastal Capital Group Inc. acquired a new position in shares of Agilent Technologies during the 2nd quarter worth about $32,000.
Several equities analysts recently weighed in on the company. ValuEngine cut Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Robert W. Baird reissued an “outperform” rating and set a $82.00 price objective (up previously from $79.00) on shares of Agilent Technologies in a research report on Thursday, August 15th. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price target for the company. in a report on Monday, August 19th. Piper Jaffray Companies upped their price target on Agilent Technologies from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, August 15th. Finally, UBS Group cut Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 price target for the company. in a report on Friday. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Agilent Technologies has an average rating of “Buy” and a consensus target price of $84.00.
Agilent Technologies stock traded up $0.57 during trading hours on Monday, hitting $75.14. The stock had a trading volume of 67,545 shares, compared to its average volume of 1,958,845. The company has a 50-day moving average of $75.06 and a two-hundred day moving average of $73.28. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27. The company has a market cap of $23.19 billion, a PE ratio of 26.88, a price-to-earnings-growth ratio of 2.07 and a beta of 1.42. Agilent Technologies Inc has a fifty-two week low of $61.01 and a fifty-two week high of $82.27.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.04. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same period in the prior year, the company posted $0.67 EPS. The company’s revenue was up 5.6% compared to the same quarter last year. As a group, analysts forecast that Agilent Technologies Inc will post 3.08 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be paid a $0.164 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $0.66 annualized dividend and a dividend yield of 0.87%. Agilent Technologies’s dividend payout ratio is currently 23.66%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: What is a good dividend yield?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.